|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-11-6
|
|
pubmed:abstractText |
A prospective Phase I dose escalation study was conducted to determine the maximally tolerated radiation dose in men treated with three-dimensional conformal radiotherapy (3D-CRT) for localized prostate cancer. This is a preliminary report of toxicity at Level III (79.2 Gy) on 3D Oncology Group/Radiation Therapy Oncology Group (RTOG) 9406.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:CoxJames DJD,
pubmed-author:EarleJohn DJD,
pubmed-author:MarkoeArnold MAM,
pubmed-author:MichalskiJeff MJM,
pubmed-author:PerezCarlos ACA,
pubmed-author:PollackAlanA,
pubmed-author:PurdyJames AJA,
pubmed-author:RoachMackM3rd,
pubmed-author:RyuJanice KJK,
pubmed-author:SandlerHoward MHM,
pubmed-author:WinterKathrynK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1036-46
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).
|
|
pubmed:affiliation |
Department of Radiation Oncology, University of California at Davis, 4501 X Street, Suite G126, Sacramento, CA 95817, USA. janice.ryu@ucdmd.ucdavis.edu
|
|
pubmed:publicationType |
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase I
|
